Thalassemia is a genetic disorder occurs as a result of the imbalance in the construction of haemoglobin chains cause haemolytic anaemia. This study was aimed to evaluate the serum level of immunological parameters (Transforming growth factor beta1, Interleukin-23) and hematological parameters in patients with alpha and beta thalassemia at Kerbala province. And was conducted at Kerbala Children's Hospital / Thalassemia Department / Kerbala Governorate during the period from November 2017 to May 2018. Seventy patients involved 48 beta thalassemia patients and 22 alpha thalassemia patients with age ranged 10-20 years old and ten matched healthy controls were enrolled in the study. Result exposed non-significant increase (p>0.05) in IL-23 and TGF-β in thalassemia patients compared with control group. In β-thalassemia patients the results of the current study indicated that non-significant positive correlation between IL-23 with WBC, there was non-significant positive correlation between TGF-β1 with WBC and PLT. As for β-thalassemia patients the present study showed non-significant positive correlation between IL-23 with Hb and WBC, and there was non-significant positive correlation between TGF-β1 with WBC. The study showed changes in the immunological parameters in patients with thalassemia of both types, as the serum level of both IL-23 and TGF-β1 were raised in addition to changes in hematological and Biochemical parameters.
INTRODUCTION
Thalassemia is common genetic disorder, especially in the Mediterranean, patients with major thalassemia suffer from haemolytic anemia since the early years of life in addition to weakness in a number of organs that the most commons homozygous cases it is considered severe and fatal unless blood transfusion begin at an early stage 1 . The main reason of thalassemia is the abnormalities in the synthesis of globin chains and the imbalance between them, in β-thalassemia this cause large amount of unpaired alpha globin chain that lead to the destruction of erythroid, the expansion of erythroid marrow appears on the growth of face bone 2 . Types of thalassemia are vary according to the type of infected globin genes 3 . Alpha thalassemia occurs due to the lack or absence of alpha-globin chain on chromosome 16 4 , beta thalassemia occurs because of the deficiency or absence of beta chain synthesis due to a localized mutation or deletion in the betaglobin gene on chromosome 11 5 .
The pathogenic factors of thalassemia are hemolysis, ineffective erythropoiesis and the elevation in the absorption of iron, the defect in erythrocytes and precursor of erythroid that result from the first two factors are eliminated by phagocytosis of monocyte and macrophage which are subjected to hyperplasia and become hyperactive, and because of this hyper activity there will be defects in the phagocytosis of microorganisms 6 .
There are many disorders in the immune system of β-thalassemia patients including cell mediated immunity 7 and both functional, quantitative and other components of the immunity 8 , involving immunoglobulins increasing, complement system with lower activity and decline in granulocyte phagocytosis and the opsonisation 9 .
Iron and proteins that bind to it have an effect on immunity as it modifies the immune system properties. An increase in the amount of the iron has harmful effects on the patient's immunity 10 . Iron accumulation effects are involving: modified the distribution of lymphocyte in various immune system compartments' and alteration in the subsets of T-lymphocyte 11 . Iron accumulation also works on accelerating the aging of patients' immunity due to the formation of reactive oxygen radicals that cause peroxidative injury to the tissue, where it effects the function of T cell and decrease antigen response 12 , prevent division of the cell, shorting the length of the telomere and decline level in the co-stimulatory receptors that stimulate the response of T cell proliferative 13 . In addition, The toxicity of iron is responsible of deficiency of immunity in beta thalassemia patients, these abnormalities include: disturbance in the activity of Neutrophils and Macrophages in their chemotaxis and phagocytosis, lower the activity of the Natural killer cells, alteration in the responses of cytokines, impaired in the proliferative response of lymphocytes to antigens and mitogens and alteration in the function of T and B lymphocytes 13 .
Thalassemia patients suffer from lower state of systemic inflammatory with a high level of neutrophil, leukocyte and lymphocyte 14 , the high level of lymphocyte counts is due to blood transfusion that leads to constant challenge of the antigen 15 .
TGF-b1 gene is a risk agent for the decrease in bone density 16 . The effective erythropoiesis work on inhibited the transforming growth factor-β (TGF-β) that is increased with stress of the cells 17 .
Aim of the study is Estimate the serum level for IL-23 and TGF-β1 in patients with alpha and beta thalassemia.
METHODS
This study was organized at Thalassemia department / Kerbala Hospital for children / Kerbala Province during the period from November 2017 to May 2018. The practical part of the study was performed at the laboratories of children Hospital and Al-Hussain Hospital, the collection of the samples included 70 patients with thalassemia 33 males and 37 females whose ages ranged between 10-20 years old. The patients divided into two groups, the first group included forty eight patients with β-thalassemia major where the number of the female was 23 and the number of the males was 25, the second group included twenty two patients with á-thalassemia where the number of the females was 14 and the number of the males was 8.
Patients who faced the following conditions were except from the current study who is suffering from: diabetes mellitus, Hepatitis, iron deficiency anemia and patients who was taking medication (antioxidant drug and chelation therapy) before 2 to 3 days from the collection of serum. The control group contained from 10 normal individuals 6 females and 4 males with age range between 10-20 years old, who were not taking medication and had negative history of hematological disease and were free from anaemia, diabetes mellitus and liver disease. The patients were identified by physician based on history and clinical examination. Blood samples were gathered from each patient in the morning before blood transfusion by venipuncture using Ten milliliters disposable syringes. Around the arm of the patient tourniquet was applied then sterilized the skin with 70% ethyl alcohol before the collection of the blood.
The Hematologic parameters were measured by auto-analyzer device known as sysmex KX 2, Japanese; liver function test (ALT, ALP, AST) and renal function test (urea, creatinine) were estimated by the use of auto-analyzer known as Cobas Integra 400 Plus, Germany; and the measurement of ferritin were done by VIDAS, France.
Enzyme linked immunosorbent assay (ELISA)
IL-23 and TGF-β1 were measured according to sandwich-ELIZA by Elabscience, China. 100uL of standards or samples were added to each well of the plate, Biotinylated Detection Antibody in 100µL was added, then incubated for 45 minutes at 37°C. The solution was aspirated for 3 times. HRP Conjugate was added to each well (100 µL) then the plate was incubated for 30 minutes at 37°C. The solution was aspirated or decanted from each well for 5 times, Substrate Reagent was added to each well (90 µL), then 50µL of Stop Solution was added to each well. The optical density (OD value) of each well was determined at once, using a micro-plate reader set 450 nm, The results were expressed in pg/mL.
Statistical analysis
Data was analyzed using the software statistical package for social sciences (SPSS version 18) and the results were presented as mean ± standard error (Mean ± E.R). One-way analysis of variation (ANOVA test) for more than two independent means was used for statistical analysis of the significance differences of the quantitative data. The Pearson's correlation coefficient test was used as appropriate for correlation between two quantitative data in different groups. P-values ≤0.05 were considered statistically significant.
RESULTS
In β-thalassemia patients compared to the control group the statistical analysis showed non-significant decrease (P>0.05) in MCV and MCH the result was in agreement with 18 . Moreover, a high significant decrease (P≤ 0.01) in Hb, this result is in agreement with 19, 20 . Also showed non-significant increase (P>0.05) in PLT, this is disagreed with 18 and there is a significant increase (P≤0.05) in ferritin, our finding are in agreement with 21 . In Alpha patients compared to control groups, the statistical analysis showed high significant decrease (P ≤0.01) in MCH and MCV, due to the lack of transfer of packed red cell (PRC) this result agreed with 22 . And significant decrease (P ≤0.05) in Hb concentration in serum of patients this result was compatible with 22 . Also study showed non-significant increase (P >0.05) in ferritin level, this result was in agreement with 23 .
Statistical analysis in thalassemia patients showed non-significant different increase (P >0.05) in WBC in both groups of thalassemia patients compared to healthy control group this result was in agreement with 24 . non-significant higher (P >0.05) in PLT, this result was disagreement with 25 . as presented in Table 1 .
According to serum IL-23 and TGF-β1 levels there were non-significant differences increases (P>0.05) in thalassemia patients as shown in Table 1 , these results are disagreement with 26 .
In thalassemia Patients compared to control group, serum urea level was non-significant increase (P >0.05), this result was disagreement with 27 .
While, serum creatinine level was highly significant decrease (P ≤0.01), this result was agreement with 28, 29 Also, the levels of ALT and ALP were significantly higher (P ≤ 0.05) this result was similar to 28 , and the level of AST was non-significant differences increases (P >0.05), this agreed with 30 and disagreement with 31 as shown in Table 2 . Nafady 32 showed significant higher levels of ALT and AST in β-thalassemia patients as in our results, which may indicate acute or chronic liver injury 33 . In a-thalassemia and β-thalassemia patients the results of the current study indicated that there was non-significant negative correlation between IL-23 with Hb and ferritin. Also there was non-significant negative correlation between TGF-β1 with ferritin, as presented in Table 3 .
DISCUSSION
Depending on the type of thalassemia, the change in the hematological parameters occurs. Low levels of mean corpuscular hemoglobin (MCH) < 27 pg or mean corpuscular volume (MCV) < 78 fl considered as indicator of thalassemia 34, 24 .
The liver is the main iron store, where 70% of the total iron content in the body is stored in the liver 35 . The previous study of Bilto and Assaf 36 showed that there is an increase in the amount of iron and ferritin in the serum of Iraqi thalassemia patients, accumulation of iron leads to increase absorption of iron in the intestine, the main cause of oxidative damage to organelles of the cell and erythrocytes in thalassemia patients is due to increase in iron overload 37 . And that damage is due to susceptible of thalassemia patients' erythrocytes to auto-oxidant in comparison to the control group 38 .This susceptible is due to high content of polyunsaturated fatty acid in the membrane of erythrocytes and the high concentration of hemoglobin and oxygen in cell which is the main source of ROC 39 , and is also because the inability of erythrocytes to synthesis damage components of cells 40 .
Antioxidants that present in the erythrocytes routinely make them resistance to oxidative damage, but for patients suffering from thalassemia there are important factors responsible for abnormalities of physiologic and function: life of red blood cells is short, turnover of iron is rapid and excessive deposition of iron in tissues, this accumulation of iron considered very harmful in patients because low solubility of iron and it is ability in stimulating the formation of toxic oxidants 41, 42 .
Moreover, the presence of the free iron in the blood and tissues is due to chronic blood transfusion, which leads to accumulation of iron that may exceed the ability of detoxification of ferritin 43 .
White blood cells is higher in Beta thalassemia patients than in controls, the increase number in the red blood cells that is immature leads to observe a high number of white blood cells as a result of the error in cell counter which is identify as WBCs 34 . Also inflammations and abnormalities that affected thalassemia patients led to an increase in the level of white blood cells which considered an indicator of infection with viruses or microbes 44 .
Platelets levels were high in thalassemia patients and that may be due to splenctomized in some patients 45 . The high levels of ferritin in serum occur as a result of iron accumulation, the increasing in iron is due to chronic blood transfusion or hemolysis of erythrocytes 46 .
TGF-β1 its effect on immunity and the status of inflammation 47 , TGF-β1 produced by phagocytes cells or cells that are infected, its important was manifested in the differentiation and activation of T-regulatory cells 48 . Through levels of both pro-inflammatory cytokines IL-23 and immunosuppressive cytokines TGF-β1 in the serum, lymphocytes functional status is determined in patients with thalassemia, in compration with control group 26 . The increasing in the level of both indicates an inflammatory state and this is mean suppression the immune response of T-cell 26, 49 .
Liver and Kidney parameters are useful indicators of inflammation and can also be used to diagnose damaged organs and tissues 28 . In clinical medicine, Creatinine considered important parameter to detect upon the function of kidney 50 , study of cimcek 51 has been shown that the high level of creatinine indicates that capacity of kidney functions is low. Patients with a high degree of anemia and increased in the oxidation lead to abnormalities of renal tubular, the severity of these disorder is related to degree of anemia, but these imbalance occur at a lower rate in patients who take iron chelating treatment and transfused continuously 52 , same observation in β-thalassemia patients but with less severe than β-thalassemia patients and that is obvious through lower level of ferritin in serum, anemia and growth failure also in lower degree than β-thalassemia patients 53 .
Previous study of Adil 54 showed the same result of our finding that patients had an increase in the ALP, which might be due to damage of the liver.
In general, elevated of these parameters (ALT, ALP and AST) are considered as indicator of Journal of Pure and Applied Microbiology liver damage and also impaired of liver function 55 . Transforming growth factor-β1 (TGF-β1) is considered an inflammatory cytokine has a part in enhancing the proliferation of fibroblast and the accumulation of matrix in tissues, TGF-β1 is excreted by antigen stimulated T-cells 56 , CD4+ CD25+ regulatory T-cells (Treg) that are occur naturally are mainly produce TGF-β1, in thalassemia patients the high level of TGF-β1 is act on increase the frequencies of CD4+ CD25+ Treg and suppression of T-cell immunity 57 , TGF-β1 is promote differentiation T-cells that are produce IL-17 that have a link with IL-23 which are contributed to several autoimmune and inflammatory disease 58 .
In thalassemia patients precipitation of iron in the epithelial cells and reticuloendothelial may influence the production and regulation of TGF-β1 and therefore effect on its level in the circulation, in children with thalassemia major the presence of TGF-β1 in the circulation is considered Not a good sign for fibrotic responses unlike other fibrotic diseases 59 , patients with fibrotic disease have higher TGF-β1 level in their alveolar fluid and their circulation 60 , some observations in β-thalassemia patients with multi-transfused are the activated of T lymphocytes. Though T-cell suppression TGF-β1. These may have implications of the immune system for the associations between premature aging and repeated immune activation this result the immune resources exhaustion 61 , moreover, chronic immune activation and blood transfusion might induce Treg cells, that act on the suppression of effector functions of T-cell. at the end this profile of cytokine can be used clinically as a related marker for appreciating the severity of the disease, an index in following the disease and therapeutic intervention 18 . immune suppression is mediates by TGF-β1 to limit immunopathogenesis related with persistent infections and chronic inflammation. subsequently high production of IL-17 and TGF-β1 might participate to iron metabolism abnormalities and probably because of overstimulation of Th17. In fact, the deposition of iron in the reticuloendothelial system like epithelial cells and macrophages may affect the regulation of Th17 responses in patients with thalassemia and result increase in its cytokines levels in the circulation. moreover, blood transfusions in multiple times may cause the immune system is under constant alloantigen stimulation in β-thalassemia patients, in spite of the immune responses that are suppressed because of iron overload 62 .
Level of TGF-β1 in the serum does not depend on ferritin , meaning that there is no correlation between them, where the results of some previous studies such as 18 showed that The level of TGF-β1 is significantly higher in all patients whether the level of ferritin is low or high.
IL-17 and IL-23 Represents the interface between cell-mediated immunity and inflammatory response in the condition of infectious diseases and cancer, Inflammation reactions are a first line of Immune response of the host against pathogens 63 , As was explained in other studies that agreed with our study there was no relationship between IL-21 and ferritin where the levels of IL-21 did not differ in patients with low ferritin compared to patients with high ferritin, the study also showed IL-21 did not associated with the level of Hb 18
